Human T-Cell Responses to Metallic Ion-Doped Bioactive Glasses
-
Published:2024-04-19
Issue:8
Volume:25
Page:4501
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Abreu Hugo12ORCID, Lallukka Mari3ORCID, Miola Marta3ORCID, Spriano Silvia3ORCID, Vernè Enrica3ORCID, Raineri Davide12ORCID, Leigheb Massimiliano14, Ronga Mario14, Cappellano Giuseppe12ORCID, Chiocchetti Annalisa12ORCID
Affiliation:
1. Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, Università del Piemonte Orientale, 28100 Novara, Italy 2. Center for Translational Research on Autoimmune and Allergic Diseases-CAAD, Università del Piemonte Orientale, 28100 Novara, Italy 3. Applied Science and Technology Department, Politecnico di Torino, 10129 Torino, Italy 4. Orthopaedics and Traumatology Unit, “Maggiore della Carità” Hospital, 28100 Novara, Italy
Abstract
Biomaterials are extensively used as replacements for damaged tissue with bioactive glasses standing out as bone substitutes for their intrinsic osteogenic properties. However, biomaterial implantation has the following risks: the development of implant-associated infections and adverse immune responses. Thus, incorporating metallic ions with known antimicrobial properties can prevent infection, but should also modulate the immune response. Therefore, we selected silver, copper and tellurium as doping for bioactive glasses and evaluated the immunophenotype and cytokine profile of human T-cells cultured on top of these discs. Results showed that silver significantly decreased cell viability, copper increased the T helper (Th)-1 cell percentage while decreasing that of Th17, while tellurium did not affect either cell viability or immune response, as evaluated via multiparametric flow cytometry. Multiplex cytokines assay showed that IL-5 levels were decreased in the copper-doped discs, compared with its undoped control, while IL-10 tended to be lower in the doped glass, compared with the control (plastic) while undoped condition showed lower expression of IL-13 and increased MCP-1 and MIP-1β secretion. Overall, we hypothesized that the Th1/Th17 shift, and specific cytokine expression indicated that T-cells might cross-activate other cell types, potentially macrophages and eosinophils, in response to the scaffolds.
Funder
European Union’s Horizon 2020 Research and Innovation Program MUR—M4C2 1.5 of the PNRR
Reference76 articles.
1. Abreu, H., Canciani, E., Raineri, D., Cappellano, G., Rimondini, L., and Chiocchetti, A. (2022). Extracellular Vesicles in Musculoskeletal Regeneration: Modulating the Therapy of the Future. Cells, 11. 2. Global Estimates of the Need for Rehabilitation Based on the Global Burden of Disease Study 2019: A Systematic Analysis for the Global Burden of Disease Study 2019;Cieza;Lancet,2020 3. The Global Burden of Osteoporosis, Low Bone Mass, and Its Related Fracture in 204 Countries and Territories, 1990–2019;Shen;Front. Endocrinol.,2022 4. Biomaterial Types, Properties, Medical Applications, and Other Factors: A Recent Review;Agrawal;J. Zhejiang Univ. Sci. A,2023 5. Freitas, J., Santos, S.G., Gonçalves, R.M., Teixeira, J.H., Barbosa, M.A., and Almeida, M.I. (2019). Genetically Engineered-MSC Therapies for Non-Unions, Delayed Unions and Critical-Size Bone Defects. Int. J. Mol. Sci., 20.
|
|